New drug TAK-360 could help extreme daytime sleepiness
NCT ID NCT06812078
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study tests a new medicine called TAK-360 for people with idiopathic hypersomnia (IH), a condition that causes extreme sleepiness even after lots of sleep. The drug works like a brain chemical called orexin that helps keep you awake. Researchers want to see if TAK-360 is safe and can help people with IH feel more alert. About 96 adults will take either TAK-360 or a placebo pill to measure the effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC HYPERSOMNIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Takeda Site 1
RECRUITINGMontpellier, Hrault, France
-
Takeda Site 10
RECRUITINGSanta Ana, California, 92705, United States
-
Takeda Site 11
RECRUITINGRedwood City, California, 94063, United States
-
Takeda Site 12
RECRUITINGCincinnati, Ohio, 45245, United States
-
Takeda Site 13
RECRUITINGColumbia, South Carolina, 29201, United States
-
Takeda Site 14
RECRUITINGWinter Park, Florida, 32789, United States
-
Takeda Site 15
RECRUITINGHuntersville, North Carolina, 28078-5082, United States
-
Takeda Site 16
RECRUITINGDenver, North Carolina, 28037, United States
-
Takeda Site 17
RECRUITINGCincinnati, Ohio, 45245, United States
-
Takeda Site 18
RECRUITINGSan Antonio, Texas, 78229, United States
-
Takeda Site 19
RECRUITINGBrandon, Florida, 33511, United States
-
Takeda Site 2
RECRUITINGParis, 75013, France
-
Takeda Site 20
RECRUITINGKumamoto, Kumamoto, 862-0954, Japan
-
Takeda Site 21
RECRUITINGYodogawa-ku, Osaka-shi, Osaka, 532-0003, Japan
-
Takeda Site 22
RECRUITINGKohoku-ku, Yokohama-Shi, Kanagawa, 222-0033, Japan
-
Takeda Site 23
RECRUITINGKurume-shi, Fukuoka, 830-0011, Japan
-
Takeda Site 24
RECRUITINGBunkyo-ku, Tokyo, 112-0012, Japan
-
Takeda Site 25
RECRUITINGFukuoka-Shi Hakata-Ku, Fukuoka, 812-0025, Japan
-
Takeda Site 26
RECRUITINGVerona, Veneto, Italy
-
Takeda Site 27
RECRUITINGColorado Springs, Colorado, 80918, United States
-
Takeda Site 28
RECRUITINGNorfolk, Virginia, 23507, United States
-
Takeda Site 29
RECRUITINGSt Louis, Missouri, 63123, United States
-
Takeda Site 3
RECRUITINGNantes, Pays de Loire, 44093, France
-
Takeda Site 4
WITHDRAWNShatin, Hong Kong
-
Takeda Site 5
RECRUITINGBologna, 40139, Italy
-
Takeda Site 6
RECRUITINGPozzilli, Isernia, Italy
-
Takeda Site 7
RECRUITINGRome, Roma, 00133, Italy
-
Takeda Site 8
RECRUITINGMadrid, 28043, Spain
-
Takeda Site 9
RECRUITINGVitoria-Gasteiz, Alava, 1004, Spain
Conditions
Explore the condition pages connected to this study.